Objective-Circadian regulation of neutrophil homeostasis affects myocardial infarction (MI) healing. It is unknown whether diurnal variations of monocyte counts exist in the heart and whether this affects their cardiac infiltration in response to MI. Approach and Results-Murine blood and organs were harvested at distinct times of day and analyzed by flow cytometry. Ly6C high monocyte surface expression levels of chemokine receptors (CCR) were ≈2-fold higher at the beginning of the active phase, Zeitgeber Time (ZT) 13 compared with ZT5. This was because of enhanced receptor surface expression at ZT13, whereas no significant changes in total cellular protein levels were found. Most blood Ly6C high monocytes were CCR2 high , whereas only a minority was CCR1 high and CCR5 high . We also found diurnal changes of classical monocyte blood counts in humans, being higher in the evening, while exhibiting enhanced CCR2 surface expression in the morning. In support of monocyte oscillations between blood and tissue, murine cardiac Ly6C high monocyte counts were highest at ZT13, accompanied by an upregulation of cardiac CC chemokine ligand 2 mRNA. Mice subjected to MI at ZT13 had an even higher upregulation of CCR2 surface expression on circulating monocytes compared with noninfarcted mice and more elevated cardiac CC chemokine ligand 2 protein expression and more pronounced Ly6C high monocyte infiltration compared with ZT5-infarcted mice. Concomitantly, CCR2 antagonism only inhibited the excessive cardiac Ly6C high monocyte infiltration after ZT13 MI but not ZT5 MI.
T he incidence of acute cardiovascular events, such as myocardial infarction (MI) and ischemic stroke, shows a time-of-day dependency. This can be partially explained by circadian fluctuations of glucocorticoids, catecholamines, blood pressure, heart rate, blood viscosity, and platelet reactivity. 1, 2 In addition, circadian rhythms of immune cell functions have been identified. 3 Circulating leukocytes oscillate between blood and peripheral tissue, peaking in mice in the blood at Zeitgeber Time (ZT) 5 (where ZT0 refers to light on and ZT12 to lights off; resting phase in rodents) and at ZT13 (active phase) in skeletal muscle tissue and bone marrow. 4 Although differential expression of adhesion molecules and chemokines in tissues plays a critical role in modulating organ-specific leukocyte oscillations, evidence is accumulating that immune cells exhibit circadian rhythms that affect their trafficking and reactivity. 3 We have recently shown that neutrophils upregulate chemokine receptor (CCR) CXCR2 expression during the sleep to wake transition period, leading to enhanced cardiac recruitment. 5 This has crucial consequences on the healing response after a MI. Mice subjected to MI at the beginning of their active phase have larger infarcts, stronger inflammatory responses, and unfavorable healing responses, translating into a worsened cardiac function compared with littermates subjected to MI during the resting phase. 5 Whether similar diurnal variations of monocyte counts exist in the heart is unknown. It has been previously demonstrated that circadian monocyte oscillations in murine blood are regulated by the circadian transcription factor BMAL (brain and muscle arylhydrocarbon receptor nuclear translocator-like) 1, which acts as a transcriptional repressor of chemokines involved in monocyte recruitment, such as CC chemokine ligand (CCL)2. 6 Circadian oscillations in cardiac monocyte infiltration might be a major determinant of MI outcome because there is a critical balance between beneficial and detrimental monocyte responses. Although monocytes are needed for MI healing, severe monocytosis after MI impairs healing and exacerbates cardiovascular complications. 7, 8 Given that Ly6C high monocytes oscillate in the blood and CCR2 determines their capacity to leave the circulation and enter tissue, we hypothesized that timeof-day-dependent variations in CCR2 surface expression on Ly6C high monocytes might contribute to the regulation of monocyte homeostasis and the inflammatory response after MI.
Materials and Methods
Materials and Methods are available in the online-only Data Supplement.
Results
We first validated Ly6C high monocyte oscillations in murine blood ( Figure IA and IB in the online-only Data Supplement). We hypothesized that monocyte oscillations between blood and tissue might be regulated, at least in part, by changes in the expression pattern of receptors involved in monocyte migration. To clarify whether diurnal variations in CCR surface expression might occur, we measured CCR protein levels on blood monocytes at 2 distinct time points, that is, the peak (ZT5) and trough (ZT13) of monocyte numbers in the blood. Both the number of CCR high -expressing cells among Ly6C high monocytes and relative CCR surface expression levels were significantly higher at ZT13 compared with those at ZT5 ( Figure 1A and 1B). There was no difference in CCR2 surface expression levels on Ly6C low monocytes between the 2 time points ( Figure IC in the online-only Data Supplement). Among the analyzed CCRs, only CCR2 was highly expressed by nearly all Ly6C high monocytes, whereas only ≈10% to 20% of Ly6C high monocytes were CCR1 high and CCR5 high ( Figure 1A ). Intracellular staining to quantify both surface and intracellular CCR2 protein only revealed a nonsignificant trend for an increase in total CCR2 expression levels at ZT13 ( Figure 1C and 1D) . A significant increase of CCR2 expression was only detectable at the cell surface of Ly6C high monocytes ( Figure 1C−1E ). Plasma CCL2 levels were not different between ZT5 and ZT13 ( Figure ID in the online-only Data Supplement).
In agreement with Nguyen et al, 6 we found that Ly6C high monocyte counts in the blood of Ccr2 −/− mice were no longer different between ZT5 and ZT13, although CCR1 and CCR5 expression levels remained higher at ZT13 compared with those at ZT5 ( Figure IE in the online-only Data Supplement). We further noted that CCR1 and CCR5 expression was slightly higher in Ccr2 −/− mice compared with wild-type littermates at ZT5, which might be a compensatory upregulation to counterbalance the lack of CCR2 ( Figure IF in the online-only Data Supplement).
Diurnal oscillations of blood monocytes also exist in humans, 9 but it is unclear which monocyte subpopulations participate in these oscillations. Human blood monocyte subsets are distinguished based on CD14 and CD16 surface markers. The equivalent of mouse Ly6C high monocytes in humans are CD14 + CD16 − monocytes, also known as classical monocytes. 10 We compared human blood of young healthy male volunteers collected at 9 AM versus 6 PM and identified classical monocytes as the predominating monocyte subset (90% of all monocytes), with nearly 2-fold higher counts at 6 PM compared with those at 9 AM ( Figure 1F ). Similar to the murine data (and considering that mice have an opposing activity-resting cycle compared with humans), CCR2 expression on human classical monocytes was also time-ofday dependent, being higher at 9 AM compared with that at 6 PM ( Figure 1G ).
We next investigated whether the murine heart would be an organ that participates in diurnal monocyte oscillations under homeostatic conditions. Flow cytometric analysis of digested hearts indeed revealed cardiac oscillations of Ly6C high monocytes with an opposing pattern compared with the blood. In particular, we measured 2-fold higher numbers at ZT13 compared with ZT5 ( Figure 2A) . Independent of the time-of-day, the vast majority of Ly6C high monocytes (>90%) in the myocardium expressed high levels of CCR2, and there was no significant difference in CCR2 expression levels between ZT5 and ZT13 ( Figure 2B ). We also did not detect any difference in total versus extracellular CCR2 staining of cardiac monocytes between the 2 time points (data not shown). Conversely, Ccl2 mRNA levels in healthy myocardium were 9-fold higher at ZT17 compared with those at ZT5 ( Figure 2C ).
To further elucidate the mechanisms underlying diurnal changes in monocyte homeostasis, bone marrow was analyzed by flow cytometry. We determined significantly higher numbers of Ly6C high monocytes at ZT13 compared with those at ZT5 but comparable levels of CCR2 surface expression on this monocyte subset regardless of the time point ( Figure IIA To investigate whether monocyte recruitment into the myocardium under ischemic injury conditions is dependent on the time of day of MI onset, we subjected wild-type mice to MI at ZT5 or ZT13 ( Figure 2D ). Flow cytometric analysis of digested hearts 24 to 72 hours after MI revealed that ZT13 infarcts had significantly higher Ly6C high monocyte counts ( Figure 2E ) and more inflammatory Ly6C high macrophages 72 hours after MI ( Figure 2F ). While infarcted mice had overall higher circulating monocyte counts compared with baseline, their numbers were significantly lower 24 hours after ZT13 MI compared with ZT5 MI (Figure 2G ). One can speculate that circulating monocytes at ZT13 are more easily recruited to the infarcted myocardium because of higher CCR2 expression at this time point compared with those at ZT5. Consequently, higher blood counts after ZT5 MI might be explained by less recruitment into the infarcted myocardium. Of note, monocyte CCR2 surface expression is overall upregulated after MI but even more upregulated on circulating blood monocytes in mice with ZT13 infarcts ( Figure 2H ). This was accompanied by significantly higher cardiac CCL2 protein levels and 3-fold higher plasma CCL2 levels 24 hours after MI in ZT13-operated mice ( Figure 2I and 2J). Conversely, there was no difference in bone marrow CCL2 levels 24 hours after MI in ZT5 versus ZT13 infarctions (data not shown).
To confirm the role of CCR2 in diurnal monocyte recruitment patterns after MI, mice subjected to MI at the 2 different time points, as well as mice under steady state, were treated with a CCR2 antagonist. While no significant effects of CCR2 antagonism were observed at baseline, blocking of CCR2 significantly inhibited cardiac monocyte infiltration in mice with ZT13 MI but not ZT5 MI ( Figure 2K ).
Discussion
The purpose of this study was to clarify the mechanisms that control monocyte oscillations in the heart because monocytes are key players of MI healing. This is of importance because an imbalance in monocyte counts may have detrimental effects on the clinical outcome of MI patients. 12 , 13 Here we report that CCR2 surface expression varies on circulating mouse and human classical monocytes in a time-of-day-dependent manner. These variations of CCR2 surface expression do not occur on cardiac and bone marrow monocytes, suggesting a specific regulation solely in circulating monocytes. Because the reported half-life of circulating monocytes at steady state high Ly6C high monocytes in the heart at steady state. Student t test, n=3 to 4 mice per group. C, Cardiac CCL2 mRNA at steady state was measured by quantitative polymerase chain reaction (qPCR). One-way ANOVA, n=5 mice per group. D, Wild-type mice were subjected to MI at Zeitgeber Time (ZT) 5 or ZT13, respectively, and were harvested precisely 24 or 72 h after MI at ZT5 or ZT13. Flow cytometric analysis of digested hearts was performed to quantify (E) Ly6C high monocytes (Mo) at indicated time points (2-way ANOVA followed by Bonferroni post hoc test, n=3-10 mice per group) and (F) Ly6C high macrophages (MΦ) 72 h after MI. Student t test, n=4 mice per group. G, Monocyte blood counts were determined using an animal blood counter. Two-way ANOVA followed by Bonferroni post hoc test, n=11 to 16 mice per group. H, Geometric (geo) mean fluorescence intensity of CCR2 surface expression on blood Ly6C high monocytes. Two-way ANOVA followed by Bonferroni post hoc test, n=5 to 10 mice per group. I, CCL2 protein concentration within the infarcted myocardium 24 h after MI. Student t test, n=6 mice per group. J, Plasma CCL2 was measured on a multiplex assay system. Two-way ANOVA followed by Bonferroni post hoc test, n=4 to 9 mice per group. K, Baseline: wild-type mice received intraperitoneal (IP) injection of vehicle or CCR2 antagonist (RS 504393) and were harvested 24 h after injection. MI: wild-type mice were subjected to MI at ZT5 and ZT13 and received IP injection of vehicle or RS 504393 15 minutes after surgery. Tissues were harvest 24 h after MI. Cardiac Ly6C high monocytes (Mo) were quantified by flow cytometry. Two-way ANOVA followed by Bonferroni post hoc test, n=4 to 10 mice per group). Data represent means±SEM, *P<0.05. in mice is ≈20 to 22 hours 14, 15 and their production is continuous, monocyte oscillations might reflect their trafficking from the blood into tissue and back to the circulation, rather than being a consequence of senescence. In agreement with this hypothesis, monocyte progenitors in the bone marrow were not subject to diurnal changes.
Monocytes are recruited by chemokines, which interact with corresponding CCRs on the cell surface of monocytes. We found that circulating Ly6C high monocytes in the blood expressed higher surface levels of CCR2 during the beginning of the active phase, the time point when Ly6C high monocyte counts peak in heart and bone marrow but are low in the blood. Nguyen et al 6 reported circadian oscillations of CCL2 expression in monocytes under transcriptional control of BMAL1, whereas Ccr2 mRNA levels do not match with the circadian patterns of blood monocytes. This is in line with our observation that despite a trend for an increase at ZT13, total CCR2 protein levels in blood monocytes were not significantly different between ZT5 and ZT13. Instead, there might be a diurnal variation of receptor internalization and recycling to the cell surface. Given the nonsignificant trend for higher CCR2 total protein levels at ZT13, one can speculate that more CCR2 is synthesized but at the same time more rapidly externalized. The relative changes of CCR2 at the cell surface might be more pronounced and, therefore, significant. Thus, our data suggest that upregulation of CCR2 surface expression on blood monocytes and local upregulation of CCL2 levels in the heart at ZT13 promote enhanced cardiac monocyte infiltration, both at steady state and after MI. Irrespective of the time point, only highly CCR2-expressing Ly6C high monocytes were found in heart and bone marrow. This suggests that CCR2 is generally required for tissue recruitment or retention, respectively, which is strengthened by our CCR2 blocking experiments. Moreover, time-dependent regulation of CCL2 gradients might play a critical role in this process, both at steady state and after MI.
We have recently reported that neutrophils at the beginning of the active phase (ZT13) are more prone to migrate into the ischemic myocardium after MI, which is dependent on CXCR2 upregulation. 5 Similarly, MI at the beginning of the active phase, when CCR2 surface expression on circulating monocytes is highest, resulted in a significantly higher cardiac Ly6C high monocyte recruitment and inflammatory macrophage count. In support of the hypothesis that a time-of-day-dependent regulation of the CCR2 surface expression on circulating monocytes drives the described differences in their post-MI recruitment capacity, blocking of CCR2 most potently inhibited cardiac monocyte infiltration at ZT13.
In summary, the present study unveils a crucial role for the CCR2/CCL2 axis in the regulation of monocyte oscillations. Our data suggest that higher CCR2 surface expression at ZT13 renders Ly6C high monocytes to be more susceptible for migration toward local CCL2 chemokine gradients within the heart, which are also highest at this time point. Excessive monocyte infiltration after an acute MI results in unfavorable healing, heart failure, and reduced survival in experimental models. 7, 8 Our study highlights the complexity of circadian regulation of immune cell trafficking, which might be relevant in view of developing more personalized therapies for MI patients, in which the time of day of ischemia onset might be taken into consideration.
